For many years, opioids were the cornerstone of postoperative pain control, contributing to what has become a significant public health concern. This article discusses contemporary approaches to multimodal, opioid-sparing postoperative pain management in the plastic surgical patient.
After viewing this course, the participant should be able to:
- Describe the fundamental concepts of multimodal analgesia techniques and how they target pain pathophysiology.
- Effectively educate patients on postoperative pain and safe opioid use.
- Develop and implement a multi-modal postoperative analgesia regimen.
Amanda M. Murphy, MD; Siba Haykal, MD, PhD; Donald H. Lalonde, MD; Toni Zhong, MD
Plastic and Reconstruction Surgery® Editors:
Editor-in-Chief: Rod J. Rohrich, MD
Co-Editor: James M. Stuzin, MD
Section Editor: Donald H. Lalonde, MD
Patient Safety Credit:
Journal Article, Video Publish Date:
11/26/2022Estimated time to complete this course:
Directly provided by the American Society of Plastic Surgeons® (ASPS®)
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.
Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. Dr. Zhong has received funds from the Canadian Institutes for Health Research, for the Foundation Scheme & New Investigator awards (2015 to 2020); the Canadian Breast Cancer Foundation; the Canadian Cancer Society, for the MC-CAT multicenter clinical trial; and from the PEGI single-center randomized controlled trial. The remaining authors have no financial interest to declare in relation to the content of this article. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.
Return Policy for Downloaded and Viewable Products
Products which are downloaded or viewable after purchase may not be returned. By placing an order you are agreeing to the product return terms and conditions set forth by this site. ASPS Shop Return Policy
Product Code: 28679